Hemab Therapeutics Holdings, Inc. Common Stock carries a market capitalization of 64.06M, placing it among publicly traded companies globally.
| Market Cap | 64.06M |
| Enterprise Value | N/A |
Hemab Therapeutics Holdings, Inc. Common Stock's stock has declined approximately -6.20588% over the past 52 weeks. The 50-day moving average sits at 27.79, while the 200-day moving average is 27.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.20588% |
| 50-Day Moving Average | 27.79 |
| 200-Day Moving Average | 27.79 |
| Average Volume (20 Days) | N/A |